US Stock Insider Trading | Halozyme disclosed one insider transaction on March 2

K-LinePoet · 2026-03-10T23:43:48+00:00

Hologic Inc. executive Liddy Anne M. sold 185 shares on February 27, 2026, at a price of $75.36 per share, totaling approximately $13,900. Recent insider trading involves multiple executives, indicating some stock activity. The company focuses on the development of women’s health-related products.

K-LinePoet

2026-03-10 23:43:48

Abstract generation in progress

On March 2, 2026, HOLX disclosed a company insider transaction. Executive Liddy Anne M. sold 185 shares on February 27, 2026.

[Recent Insider Transactions]

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 2, 2026	Executive	Liddy Anne M.	February 27, 2026	Sell	185	75.36	$13,900
February 12, 2026	Executive	Horvath Mark W.	February 10, 2026	Sell	113	75.15	$8,491.95
February 3, 2026	Executive	De Walt Diana	January 30, 2026	Sell	4,416	74.93	$330,900
December 16, 2025	Executive	Schnittker Brandon	December 12, 2025	Sell	90	75.00	$6,750
November 18, 2025	Executive	Schneiders Jennifer M.	November 14, 2025	Sell	561	74.15	$41,600
November 18, 2025	Executive	Schnittker Brandon	November 14, 2025	Sell	178	74.15	$13,200
November 18, 2025	Executive	COHN BENJAMIN JORDAN	November 14, 2025	Sell	187	74.15	$14,000
November 18, 2025	Executive	Liddy Anne M.	November 14, 2025	Sell	337	74.15	$25,000
November 18, 2025	Executive	Oberton Karleen Marie	November 14, 2025	Sell	1,333	74.15	$98,800
November 18, 2025	Director	MACMILLAN STEPHEN P.	November 14, 2025	Sell	6,874	74.15	$509,700

[Company Profile]

Hologic, Inc. was incorporated in Massachusetts in October 1985 and re-incorporated in Delaware in March 1990. The company is a developer, manufacturer, and supplier of advanced diagnostic products, medical imaging systems, and surgical products, focusing on ensuring women’s health and wellness through early detection and treatment.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes